3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
3
Stomach Neoplasms
1
Psychological Well-Being
1
Psoriasis
1
Peripheral Nervous System Diseases
1
Osteoarthritis
1
Neoplasms
1
Multiple Myeloma
1
Motor Activity
1
Lung Neoplasms
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Cardiovascular Diseases
1
Autoimmune Diseases
1
Arthritis, Rheumatoid
1
Arthralgia
1
Interventions
fludarabine
2
Specimen Handling
2
Cyclophosphamide
2
thymoglobulin
1
remdesivir
1
prednylidene
1
deltacortene
1
carmustine, poliferprosan 20 drug combination
1
cabozantinib
1
Vitamin D
1
Surveys and Questionnaires
1
Standard of Care
1
Prednisone
1
Practice Guidelines as Topic
1
Platinum Compounds
1
Peripheral Blood Stem Cell Transplantation
1
Nivolumab
1
Methods
1
Melphalan
1
Ipilimumab
1
Interviews as Topic
1
Fish Oils
1
Fatty Acids, Omega-3
1
Etoposide
1
Eicosapentaenoic Acid
1
Educational Status
1
Early Intervention, Educational
1
Docosahexaenoic Acids
1
Cytarabine
1
Cholecalciferol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Autoimmune Diseases
×
Fish Oils
×
1 year
×
Clear all
NCT01351805
2025-12-03
VITAL
Brigham and Women's Hospital
Phase NA
Completed
25,871 enrolled
15 charts